PMID- 8896808 OWN - NLM STAT- MEDLINE DCOM- 19970218 LR - 20170301 IS - 0006-8993 (Print) IS - 0006-8993 (Linking) VI - 734 IP - 1-2 DP - 1996 Sep 23 TI - Central antagonism of atrial natriuretic peptides on behavioral and hormonal responses to angiotensin II: mapping with c-fos. PG - 55-60 AB - The expression of the immediate early gene (IEG) c-fos has been used to map the antagonistic effects between atrial natriuretic peptide (ANP) and angiotensin II (Ang II). Intracerebroventricular (i.c.v.) infusions of ANP (100, 250, 1000 or 2000 pmol) did not induce detectable c-fos expression in the forebrain when compared with CSF-treated rats. Neither did C-type natriuretic peptide (CNP, 10, 100, 500 or 1000 pmol), another member of the natriuretic peptide family, which appears to be predominant in the brain. ANP was found to inhibit the water intake and corticosterone release induced by i.c.v. infusions of Ang II. However, ANP could not suppress the c-fos expression in the organum vasculosum of the lamina terminalis (OVLT), medial preoptic nucleus (MNPO), subfornical organ (SFO), supraoptic (SON) and paraventricular (PVN) nuclei of forebrain induced by the same dose of Ang II. The activation of second messenger pathways following i.c.v. infusion of Ang II may result in two different sets of effects: immediate behavioural and physiological responses (presumably through postsynpatic responses in neurons sensitive to Ang II), and the delayed expression of c-fos (and other IEGs proteins) which control the expression of late response genes. Whilst there is considerable, and growing evidence that IEGs mark the pattern of neuronal activity induced by peptides such as Ang II, the precise role played by these gene products is still problematical and awaits clarification by further experiments. FAU - Zhu, B AU - Zhu B AD - Department of Anatomy, University of Cambridge, UK. FAU - Herbert, J AU - Herbert J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Hormones) RN - 0 (Proteins) RN - 0 (Proto-Oncogene Proteins c-fos) RN - 11128-99-7 (Angiotensin II) RN - 127869-51-6 (Natriuretic Peptide, C-Type) RN - 85637-73-6 (Atrial Natriuretic Factor) RN - W980KJ009P (Corticosterone) SB - IM MH - Angiotensin II/*pharmacology MH - Animals MH - Atrial Natriuretic Factor/*antagonists & inhibitors/pharmacology MH - Behavior, Animal/*physiology MH - Brain/drug effects/*metabolism MH - Corticosterone/metabolism MH - Drinking/drug effects MH - Hormones/*metabolism MH - Injections, Intraventricular MH - Male MH - Microinjections MH - Natriuretic Peptide, C-Type MH - Proteins/*pharmacology MH - Proto-Oncogene Proteins c-fos/*metabolism MH - Rats MH - Rats, Inbred Strains MH - Tissue Distribution EDAT- 1996/09/23 00:00 MHDA- 1996/09/23 00:01 CRDT- 1996/09/23 00:00 PHST- 1996/09/23 00:00 [pubmed] PHST- 1996/09/23 00:01 [medline] PHST- 1996/09/23 00:00 [entrez] AID - 0006-8993(96)00615-4 [pii] PST - ppublish SO - Brain Res. 1996 Sep 23;734(1-2):55-60.